• Prenatal RhD NIPT Cell-free DNA Screening (UNITY Fetal Antigen™, Fetal RhD NIPT Panorama™)
  • miR Sentinel™ (microRNA) Prostate Cancer Test
  • Glucose Tolerance Test, 2 Hour Post-75g Oral Ingestion
  • Vitamin B2 (Riboflavin)
  • Culture, Feces, Routine, with Campylobacter and Shiga Toxin Antigens, by EIA
  • Cortisol, Salivary
  • Osteogenesis Imperfecta and Low Bone Density Gene Mutation Panel, NGS
  • Hepatitis B Virus (HBV) Antibody Panel for Acute and Chronic Infection
  • Metanephrines, Fractionated, 24 Hour, Urine
  • E6 and E7 Gene Expression Detection Assay for Cervical Cancer (HPV OncoTect, QuantiVirus™)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

ICD10
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...